Steward Partners Investment Advisory, LLC Amgen Inc Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Amgen Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 73,551 shares of AMGN stock, worth $24.5 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

73,551

Previous 71,796 2.44%

Holding current value

$24.5 Million

Previous $20.4 Million 12.58%

% of portfolio

0.25%

Previous 0.23%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $461,126 - $560,389	1,755 Added 2.44%	73,551 $23 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $332,592 - $401,480	1,237 Added 1.75%	71,796 $20.4 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $786,788 - $887,591	3,077 Added 4.56%	70,559 $20.3 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $2.51 Million - $3.12 Million	11,496 Added 20.53%	67,482 $18.1 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $33,854 - $40,032	-158 Reduced 0.28%	55,986 $12.4 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $295,107 - $359,686	1,307 Added 2.38%	56,144 $13.6 Million
Q4 2022 Feb 15, 2023	SELL	$229.03 - $291.01 $348,354 - $442,626	-1,521 Reduced 2.7%	54,837 $14.4 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $151,061 - $170,369	673 Added 1.21%	56,358 $12.7 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $190,105 - $211,553	-824 Reduced 1.46%	55,685 $13.5 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $1.35 Million - $1.49 Million	6,159 Added 12.23%	56,509 $13.7 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $105,406 - $120,628	-530 Reduced 1.04%	50,350 $11.3 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.93 Million - $2.27 Million	-9,110 Reduced 15.19%	50,880 $10.8 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $2.34 Million - $2.59 Million	-9,998 Reduced 14.29%	59,990 $14.6 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $1.17 Million - $1.37 Million	5,284 Added 8.17%	69,988 $17.4 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $124,418 - $148,160	575 Added 0.9%	64,704 $14.9 Million
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $1.25 Million - $1.39 Million	5,332 Added 9.07%	64,129 $16.3 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $4.11 Million - $5.05 Million	20,793 Added 54.71%	58,797 $13.9 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $273,906 - $363,275	-1,503 Reduced 3.8%	38,004 $7.7 Million
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $77,765 - $99,955	411 Added 1.05%	39,507 $9.52 Million
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $242,883 - $291,024	1,395 Added 3.7%	39,096 $7.57 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $77,015 - $90,279	-462 Reduced 1.21%	37,701 $6.95 Million
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $5,064 - $5,708	-28 Reduced 0.07%	38,163 $7.25 Million
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $109,002 - $127,240	611 Added 1.63%	38,191 $7.43 Million
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $104,132 - $117,396	-562 Reduced 1.47%	37,580 $7.79 Million
Q2 2018 Jul 20, 2018	BUY	$166.05 - $186.51 $1.61 Million - $1.81 Million	9,698 Added 34.1%	38,142 $7.04 Million
Q1 2018 Apr 20, 2018	BUY	$169.43 - $198.0 $30,666 - $35,838	181 Added 0.64%	28,444 $4.85 Million
Q4 2017 Jan 19, 2018	BUY	$168.79 - $188.59 $254,535 - $284,393	1,508 Added 5.64%	28,263 $4.92 Million
Q3 2017 Nov 22, 2017	BUY	$167.29 - $191.0 $604,084 - $689,701	3,611 Added 15.6%	26,755 $4.99 Million
Q2 2017 Nov 22, 2017	BUY	N/A	5,262 Added 29.43%	23,144 $3.99 Million
Q1 2017 Nov 22, 2017	BUY	N/A	8,678 Added 94.29%	17,882 $2.93 Million
Q4 2016 Nov 22, 2017	BUY	N/A	9,204	9,204 $1.35 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Amgen Inc Transaction History